Melanoma Drug Combo Wins Accelerated U.S. Approval
January 9, 2014 — LONDON (Reuters) - A combination treatment from
GlaxoSmithKline for melanoma won accelerated approval from U.S.
Palladium-103 plaque radiation therapy spares vision in choroidal melanoma
December 5, 2013 — NEW YORK (Reuters Health) - Palladium-103 plaque radiation
therapy can preserve vision in patients with T3- and T4-staged
choroidal melanoma, according to a new analysis.
Experimental melanoma drug continues to show promise
November 18, 2013 — (Reuters) - Early data from a small trial of Merck & Co
Inc's experimental immunotherapy cancer drug, known as MK-3475,
show that about half of advanced melanoma patients treated with
the highest dose of the drug experienced tumor shrinkage.
Select news items provided by Reuters Health